Anna Klimovich | Biochemistry | Young Scientist Award

Dr. Anna Klimovich | Biochemistry | Young Scientist Award 

Dr. Anna Klimovich | G.B. Elyakov Pacific Institute of Bioorganic Chemistry Far-Eastern Branch of the Russian Academy of Sciences | Russia

Dr. Anna Klimovich is a PhD candidate in biochemistry with a decade of experience as a research fellow, specializing in the investigation of biologically active compounds derived from marine organisms of the Far Eastern and tropical seas using advanced experimental models of human pathologies in laboratory animals. She works as a research assistant in the Laboratory of Molecular Pharmacology and Biomedicine at the Pacific Institute of Bioorganic Chemistry, contributing extensively to fundamental and applied biomedicine. Her scientific portfolio includes 40 publications indexed in Web of Science and Scopus, supported by 199 citations across 162 documents and an h-index of 8, reflecting her strong research impact. She has completed seven research projects and is an inventor or co-inventor on seven patents focused on bioactive marine compounds and their therapeutic potential. Her research areas span biology, biochemistry, biomedicine, natural biologically active substances, and preclinical trials, with collaborative work involving Far Eastern Federal University in Vladivostok. Dr. Klimovich has contributed significantly to the characterization of marine peptides and metabolites, including the sea anemone peptide HCRG21, which exhibits analgesic, anti-inflammatory, and anxiolytic activities and demonstrates therapeutic potential for allergic dermatitis and psoriasis. She has also studied the peptide HCIQ2c1 with anti-inflammatory and neuroprotective properties, and the sea anemone peptides Hcr 1b-2, Hcr 1b-4, and AnmTX Sco 9a-1, which show strong anxiolytic, anti-inflammatory, and analgesic effects. Her work further includes discovering the antidiabetic and antiglycemic activities of the peptide Mgf, evaluating antimicrobial and antitumor effects of phenylphascaplysine alkaloid derivatives, and identifying the ability of triterpene glycosides from sea cucumbers—Cucumarioside A0-1, Djakonovioside A—and the peptide Hct-S3 to inhibit tumor metastasis. Additionally, she contributed to demonstrating that asterripeptides A–C from marine fungi possess therapeutic activity in treating infected wounds. Her research advances marine-derived therapeutic discoveries with high relevance to pharmacology, biotechnology, and translational biomedicine.

Profiles: Scopus | Orcid

Featured Publications

Klimovich, A., Kvetkina, A., Deryavko, Y., Priymenko, N., Popkova, D., Bystritskaya, E., Isaeva, M., Gladkikh, I., Sintsova, O., & Leychenko, E. (2025). TRPV1 blocker, peptide HCRG21 from sea anemone Heteractis magnifica, exhibits effectiveness in psoriasis and dermatitis in in vivo models. International Journal of Molecular Sciences, 26(21), 10644. https://doi.org/10.3390/ijms262110644

Klimovich, A. A., Chingizova, E. A., Pislyagin, E. A., Kotelnikov, V. N., & Shperling, I. A. (2025). Eksperimental’no-funktsional’naya otsenka ranozazhivlyayushchey aktivnosti gidrogelya na osnove karboksimetiltsellyulozy s biologicheski aktivnymi veshchestvami iz gidrobiontov Tikhogo okeana pri termicheskom ozhoge [Experimental and functional evaluation of the wound-healing activity of a carboxymethylcellulose-based hydrogel with bioactive substances from Pacific Ocean hydrobionts in a thermal burn model]. Clinical and Fundamental Medicine, 2, 5–12. https://doi.org/10.24866/3033-5485/2025-2/5-12

Zhidkov, M. E., Smirnova, P. A., Grammatikova, N. E., Isakova, E. B., Shchekotikhin, A. E., Styshova, O. N., Klimovich, A. A., & Popov, A. M. (2025). Comparative evaluation of the antibacterial and antitumor activities of marine alkaloid 3,10-dibromofascaplysin. Marine Drugs, 23(2), 68. https://doi.org/10.3390/md23020068

Klimovich, A. A., Kvetkina, A. N., Deryavko, Y. V., Priymenko, N. A., & Leychenko, E. V. (2024). Peptide TRPV1 channel blocker, HCRG21, effectively suppresses inflammation in a calcipotriol-induced allergic dermatitis model. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18, (Issue no. pending). https://doi.org/10.1134/S1990750824601127

Pavlenko, A. P., Klimovich, A. A., Yurchenko, E. A., Kvetkina, A. N., & Leychenko, E. V. (2024). Sea anemone Heteractis magnifica toxin Hct-S3 suppresses the migration of solid Ehrlich adenocarcinoma cells inoculated into BALB/C mice. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18, (Issue no. pending). https://doi.org/10.1134/S1990750824601206

Klimovich, A. A., Styshova, O. N., Popov, A. M., Moskvina, T. V., Tsybulsky, A. V., Derunov, D. A., & Stonik, V. A. (2020). Experimental study of therapeutic efficacy of the topical preparation “Kourochitin” in skin allergy. Letters in Drug Design & Discovery, 17(10), 1234–1241.

Huiqing Jiang | Nucleic Acid | Outstanding Contribution Award

Prof. Huiqing Jiang | Nucleic Acid | Outstanding Contribution Award

Prof. Huiqing Jiang | Hebei Medical University | China

Prof. Huiqing Jiang is a distinguished Professor, Chief Physician, and Doctoral Supervisor at The Second Hospital of Hebei Medical University, where he also serves as Director of the Hebei Institute of Digestive Diseases and the Hebei Key Laboratory of Digestive Diseases. A recipient of the prestigious Special Government Allowance from the State Council of China, he has made outstanding contributions to the diagnosis and treatment of digestive system diseases. His clinical expertise encompasses endoscopic diagnosis and therapeutic interventions for gastrointestinal disorders, including endoscopic resection of early cancers and polyps, stricture dilation, stent placement, treatment of esophageal varices in cirrhosis, and biliary stone extraction with pancreatic stent insertion. As a pioneer in Hebei Province, he has introduced and advanced multiple endoscopic techniques that have transformed clinical practice and improved patient outcomes. His research primarily focuses on chronic liver diseases, particularly liver fibrosis, and gastrointestinal tumors, where he has established himself as a leading authority in digestive disease research. Prof. Jiang has served as the principal investigator for two National Natural Science Foundation of China projects and has successfully completed six provincial-level projects, earning significant recognition for his innovative contributions. His work has been honored with several prestigious awards, including the First-Class Prize of the Provincial Scientific and Technological Progress Award, three Third-Class Prizes, and the Young Teachers Award from the Huo Yingdong Education Foundation. He has published an impressive 160 peer-reviewed papers, including 11 SCI-indexed articles, with his highest impact publication appearing in the Journal of Hepatology (Impact Factor 9.334). His academic influence is reflected in his citation record of 1,866 citations across 1,714 documents and an h-index of 24, showcasing his sustained scholarly impact in the field. Additionally, he has edited or co-authored 16 authoritative medical textbooks such as Internal Medicine, Diagnostics, and Clinical Hepatology, contributing extensively to medical education and training. Prof. Jiang also holds significant editorial responsibilities, serving as Associate Editor-in-Chief of Gastroenterology and Hepatology and as a board member of several core medical journals. His leadership extends to professional associations as Standing Committee Member of the Chinese Society of Digestive Endoscopy and the Endoscopist Branch of the Chinese Medical Doctor Association, and as Chairman of both the Hebei Branch of the Digestive Endoscopist Association and the Hebei Society of Gastroenterology.

Profile:  Scopus

Featured Publications

piR-19521 facilitates cancer stem cell-like properties by enhancing ALX4 transcription via an enhancer RNA-like mechanism in colorectal cancer. International Journal of Biological Macromolecules.

Correction to: The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis. Experimental & Molecular Medicine, 51(1), 1–13.

Identification and validation of a novel predictive signature based on hepatocyte-specific genes in hepatocellular carcinoma by integrated analysis of single-cell and bulk RNA sequencing. BMC Medical Genomics.

Development and validation of risk prediction model for bacterial infections in acute liver failure patients. European Journal of Gastroenterology & Hepatology.

Effect of oxaliplatin on the activation of hepatic stellate cells and its mechanism. Journal of Clinical Hepatology.

Development and validation of a new prognostic model for patients with acute-on-chronic liver failure in intensive care unit. World Journal of Gastroenterology.

Identification of oxidative stress-related biomarkers associated with the development of acute-on-chronic liver failure using bioinformatics. Scientific Reports.

Evaluation of ITGB1 expression as a predictor of the therapeutic effects of immune checkpoint inhibitors in gastric cancer. BMC Gastroenterology.